水解物
抗氧化剂
胃蛋白酶
化学
乳鱼
生物化学
超滤(肾)
蛋白酵素
生物信息学
蛋白酶
功能性食品
胰蛋白酶
细胞毒性
食品科学
酶
肌球蛋白
二肽基肽酶
水解
肽
消化(炼金术)
保健品
体外
活力测定
酶水解
多糖
生物利用度
淀粉酶
免疫佐剂
作者
Anastacio T. Cagabhion,Wen-Ling Ko,Ting-Jui Chuang,Rotimi Emmanuel Aluko,Yu‐Wei Chang
出处
期刊:Foods
[Multidisciplinary Digital Publishing Institute]
日期:2025-10-10
卷期号:14 (20): 3456-3456
被引量:4
标识
DOI:10.3390/foods14203456
摘要
The study presents the potential of milkfish frame, a by-product of milkfish processing, as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory and antioxidant peptides with potential applications in type 2 diabetes management. Proteomic analysis identified key proteins, including 65 kDa warm temperature acclimation protein 1 and myosin heavy chain. In silico prediction (BIOPEP-UWM) guided the selection of proteases for generating DPP-IV inhibitory peptides. Enzymatic hydrolysates were produced and evaluated for bioactivity. Among the treatments, pepsin hydrolysis (2% v/v, 8 h) yielded the highest peptide content (283.64 mg/g), soluble protein (86.46%), and DPP-IV inhibitory activity (68.47%). The resulting milkfish frame pepsin hydrolysate (MFH) was further enhanced through ultrafiltration and simulated gastrointestinal digestion, which improved the DPP-IV inhibitory and antioxidant capacities. Cytotoxicity assays confirmed that MFH (0–100 μg/mL) was non-toxic to FL83B hepatocytes after 24 h. Moreover, treating TNF-α-induced FL83B cells with 10 μg/mL MFHs improved cell viability, reducing the toxicity induced by TNF-α in cells. These findings show that MFHs exhibit promising antidiabetic potential and could serve as natural alternatives to synthetic drugs for type 2 diabetes management. This also demonstrates the valorization of fish processing by-products into functional food ingredients, advancing sustainable approaches in food innovation.
科研通智能强力驱动
Strongly Powered by AbleSci AI